e-learning
resources
Munich 2006
Monday 04.09.2006
COPD and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Elevated C-reactive protein is associated with reduced lung function and exercise capacity in normal subjects. Are we born inflammed?
V. M. Pinto-Plata, H. Mullerova, B. R. Celli (Boston, United States Of America; London, United Kingdom)
Source:
Annual Congress 2006 - COPD and inflammation
Session:
COPD and inflammation
Session type:
Oral Presentation
Number:
1994
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. M. Pinto-Plata, H. Mullerova, B. R. Celli (Boston, United States Of America; London, United Kingdom). Elevated C-reactive protein is associated with reduced lung function and exercise capacity in normal subjects. Are we born inflammed?. Eur Respir J 2006; 28: Suppl. 50, 1994
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
High-sensitive C-reactive protein is associated with reduced lung function in young adults
Source: Eur Respir J 2009; 33: 382-388
Year: 2009
Cardiorespiratory fitness, pulmonary function and C-reactive protein levels in adults with diabetes
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
Leptin levels are associated with reduced lung function in men with COPD
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Circulating C-reactive protein level is negatively correlated with lung volume
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Peak exercise increases plasma IL-6 without changes in muscle redox status in healthy young subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 289s
Year: 2002
Elevated plasma fibrinogen associated with reduced pulmonary function
Source: Eur Respir J 2001; 18: Suppl. 33, 505s
Year: 2001
Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006
Are lung function abnormalities associated with reduced exercise capacity in prematurely born young people?
Source: International Congress 2018 – Prematurity and lung disease
Year: 2018
Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Association between C-reactive protein levels and outcome in acute lung injury in children
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
“Plasma pro-surfactant protein B and lung function decline in smokers.”
Source: Eur Respir J 2016; 48: 962
Year: 2016
Association of elevated CRP and IL-6 with rapid decline in lung function and exacerbation in tuberculosis destroyed lung
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Elevated baseline blood eosinophil count is related to greater lung function decline over 20-years of follow-up.
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
COPD patients exhibit abnormally increased peripheral neutrophil stiffening not different from smokers with normal lung function
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009
Total antioxidant capacity and C-reactive protein levels in patients with community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Plasma pro-surfactant protein B and lung function decline in smokers
Source: Eur Respir J 2015; 45: 1037-1045
Year: 2015
The study on the association of serum C-reactive protein level with the risk of lung cancer
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Procalcitonin and C-reactive protein levels correlate worse with organ failure than NT-proBNP levels in septic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 61s
Year: 2006
Reduced heart rate variability is associated with increased level of serum ICAM-1 in patients with sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside
Year: 2010
Is there a relationship between severity of COPD and C-reactive protein (CRP) levels?
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept